Edwards Lifesciences (EW) Raw Materials (2010 - 2026)

Edwards Lifesciences' Raw Materials history runs 13 years deep, the most recent figure standing at $202.4 million for Q1 2026.

• In Q1 2026, Raw Materials fell 21.91% year-over-year to $202.4 million; the TTM figure through Mar 2026 stood at $202.4 million (down 21.91% YoY), while the FY2025 annual figure was $196.6 million, down 18.46% from the prior year.
• Raw Materials was $202.4 million for Q1 2026 at Edwards Lifesciences, up from $196.6 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $280.0 million in Q1 2024 to a low of $196.3 million in Q4 2023.
• Historically, Raw Materials has averaged $233.0 million across 4 years, with a median of $237.3 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Raw Materials advanced 22.82% in 2024, then dropped 21.91% in 2026.
• A 4-year view of Raw Materials shows it stood at $196.3 million in 2023, then advanced by 22.82% to $241.1 million in 2024, then dropped by 18.46% to $196.6 million in 2025, then increased by 2.95% to $202.4 million in 2026.
• The last three Raw Materials figures came in at $202.4 million (Q1 2026), $196.6 million (Q4 2025), and $222.8 million (Q3 2025), per Business Quant data.